Health

The United States is poised to get a third coronavirus vaccine — this one made by Johnson & Johnson. The US Food and Drug Administration has given the vaccine emergency use authorization, the Centers for Disease Control and Prevention has recommended it, and the federal government is scheduled to start distribution almost immediately. Two vaccines

Centers for Disease Control and Prevention vaccine advisers voted Sunday to recommend the Johnson & Johnson Covid-19 vaccine for the US. It is the first of the three authorized Covid-19 vaccines that comes in a single dose. It is a vaccine one member called “highly effective.” The US Food and Drug Administration authorized the J&J

A third vaccine is poised to join the fight against Covid-19, with 3.9 million doses expected to be available right away, a health official said Friday. That amount could increase vaccinations for states by 25% and would be delivered in as little as one or two days in the first week, said Lori Tremmel Freeman,

Americans are taking another look at Johnson & Johnson’s Covid-19 vaccine and its data after the vaccine received emergency use authorization by the US Food and Drug Administration on Saturday. And what they see might initially give them pause. For several months, public health experts have praised the approximately 95% efficacy seen in vaccines by

Even with a third vaccine nearing authorization and a rise in vaccination rates, officials say another devastating Covid-19 spike could be on the horizon depending on what the United States does next. “The question that hangs in the balance right now is, will we have a fourth surge?” Dr. Tom Frieden, the former director of

The health director in Tennessee’s largest county resigned Friday after the state health department found that 2,500 Covid-19 vaccine were either wasted or expired and two children were “inappropriately vaccinated” at a county vaccination site. A total of 2,500 doses were either expired or wasted in Shelby County over a 20-day period from February 3

Vaccine advisers to the US Food and Drug Administration voted Friday to recommend the agency grant emergency use authorization to Johnson & Johnson’s coronavirus vaccine. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend EUA of the vaccine in people 18 and older. Acting FDA Commissioner Dr. Janet Woodcock and

The US Centers for Disease Control and Prevention should be doing more to guide and encourage improved air circulation in buildings — especially in schools — to help prevent the spread of coronavirus, ventilation experts say. They say the CDC has not paid anywhere near enough attention to the role ventilation can play in helping

Canada expects to receive more than 6.5 million Covid-19 vaccines by the end of March, with tens of millions more vaccines arriving between April and June, Canadian Prime Minister Justin Trudeau said Friday. Canada has secured access to nearly 400 million doses of vaccines, but manufacturers have been slow to ship the authorized medicine. Just

Even with slowed infection rates and increased vaccinations, officials say another devastating Covid-19 spike could be on the horizon depending on what the United States does next. “The question that hangs in the balance right now is, will we have a fourth surge?” Dr. Tom Frieden, the former director of the US Centers for Disease

Just one dose of Pfizer/BioNTech’s coronavirus vaccine can induce a strong enough immune response in people who have already had Covid-19 that it could protect from future disease, according to two new papers published in the journal The Lancet on Thursday. In the United States, the vaccine is authorized as two doses taken 21 days

US Food and Drug Administration vaccine advisers are scheduled to meet Friday to discuss the potential emergency authorization of a third coronavirus vaccine for the US, this one made by Johnson & Johnson’s vaccine arm Janssen Biotech. It’s the next step in a process that could end with the new vaccine’s rollout early next week.